Ryan Mould has a strong background in analytical chemistry and drug product development. From August 2005 to May 2010, Ryan served as a QC Analyst at ImClone Systems, performing various assays including osmolality, TOC, conductivity, A280, ELISA, HPLC, SDS-PAGE, and IEF. Subsequently, Ryan joined Eli Lilly and Company, where from January 2018 to October 2025, roles included Associate Consultant Chemist and Sr. Principal Chemist focusing on drug product formulation and development, along with serving as an Advisor in Drug Product Formulation and in the role of Principal Associate, Formulation Development. Ryan holds a Bachelor of Science degree in Biological Sciences from Rutgers University, which was completed in 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices